arrow
S

Stephan von Haehling

universitaetsmedizin goettingen
H指数:98
被引数:4.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association of altered body composition with cardiac wasting in cancer with and without cardiotoxic therapy

改变的身体成分与接受和不接受心脏毒性治疗癌症患者中心脏消耗的关联

2026-10-070
OAAI
Gut Microbiota in Heart Failure with Preserved Ejection Fraction: Clinical Phenotyping and Therapeutic Opportunities

射血分数保留的心力衰竭中的肠道微生物组:临床表型分析及治疗机会

2026-09-200
OA
Exercise training for cardiovascular prevention in patients with cancer: A scientific statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-Oncology

癌症患者心血管预防的锻炼训练:欧洲心力衰竭协会、欧洲预防心脏病学协会(ESC)和ESC心血管肿瘤学委员会的科学声明

2026-07-150
OAAI
Contemporary heart failure evidence in 2025: a joint summary of key trials from the European Journal of Heart Failure and ESC Heart Failure Journal

2025年当代心力衰竭证据:欧洲心力衰竭杂志和ESC心力衰竭杂志关键试验的联合摘要

2026-01-010
OA
Adherence to guideline-directed medical treatments in heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Cardiovascular Pharmacotherapy

在心力衰竭中坚持指南指导的药物治疗。ESC心力衰竭协会 (HFA) 和ESC心血管药物治疗工作组的科学声明

2025-11-090
OAAI
The Prognostic Role of Frailty and Its Recognition With Simple FRAIL and Fried Frailty Questionnaires in Advanced Cancer Patients

虚弱及其在晚期癌症患者中的预后作用与简单FRAIL和Fried虚弱问卷的识别

2025-10-120
OAAI
Inferior Vena Cava Ultrasound to Guide Decongestion in Acute Decompensated Heart Failure

下腔静脉超声指导急性失代偿性心力衰竭的脱水治疗

2025-09-090
PRE
Clinical and echocardiographic phenotype of cardiac wasting in patients with advanced cancer

晚期癌症患者中心脏消耗的临床和超声心动图表型

2025-08-060
OAAI
Intravenous ferric carboxymaltose in heart failure with iron deficiency (FAIR-HF2 DZHK05 trial): Sex-specific outcomes

静脉用蔗糖铁在心力衰竭伴铁缺乏中的性别特异性结局(FAIR-HF2 DZHK05试验)

2025-07-310
OAAI